Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.currproblcancer.2016.12.004 http://scihub22266oqcxt.onion/10.1016/j.currproblcancer.2016.12.004 C5440194!5440194!28189263     free     free     free       Curr+Probl+Cancer 2017 ; 41 (2): 100-10 Nephropedia Template TP {{tp|p=28189263|t=2017. Renal Complications of Immune Checkpoint Blockade |pdf=|usr=}}{{28189263}} gab.com Text Renal Complications of Immune Checkpoint Blockade JO: Curr Probl Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28189263 #FOAvip Immune checkpoint inhibitors have been approved for a variety of cancer species. Renal complications in use of these agents are not very common compared with other immune related adverse events (irAE). However, it is crucial for physicians to recognize and manage renal manifestations of irAE. In this review, we will summarize the up-to-date knowledge of the clinical presentation, pathological features and management of renal irAE. In addition, we will discuss the safety of immune checkpoint inhibitors in patients with chronic kidney disease as well as in kidney transplant recipients. Twit Text FOAVip Renal Complications of Immune Checkpoint Blockade ????Curr Probl Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28189263 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28189263 #FOAvip English Wikipedia <ref>{{Cite pmid|28189263}}</ref> Renal Complications of Immune Checkpoint Blockade #MMPMID28189263 Murakami N; Motwani S; Riella LV Curr Probl Cancer 2017[Mar]; 41 (2): 100-10 PMID28189263show ga Immune checkpoint inhibitors have been approved for a variety of cancer species. Renal complications in use of these agents are not very common compared with other immune related adverse events (irAE). However, it is crucial for physicians to recognize and manage renal manifestations of irAE. In this review, we will summarize the up-to-date knowledge of the clinical presentation, pathological features and management of renal irAE. In addition, we will discuss the safety of immune checkpoint inhibitors in patients with chronic kidney disease as well as in kidney transplant recipients. äRenal Complications of Immune Checkpoint Blockade (epmc).pdf DeepDyve Pubget Overpricing